|
MARKETWATCH
Pharmaceutical Reform In South Korea And The Lessons It Provides
Hak-Ju Kim and
Jennifer Prah Ruger
Through implementation of its 2000 pharmaceutical reform, the South Korean government expected to reduce the cost of medications and improve service levels, medical appropriateness of care, and drug effectiveness. However, despite the reform’s lofty goals, unintended consequences have distorted the supply of medical services and spending. These consequences have included increasing the use of uninsured services, prescribing high-price drugs, and a growing market share for multinational drug companies. Further reforms are needed to reduce the measure’s adverse effects. This paper examines the Korean mandatory prescription system and offers an analysis of Korea’s reforms.
       What's this?
This article has been cited by other articles:
|
|
|
|
 
C. D. James, J. Peabody, O. Solon, S. Quimbo, and K. Hanson
An Unhealthy Public-Private Tension: Pharmacy Ownership, Prescribing, And Spending In The Philippines
Health Aff.,
July 1, 2009;
28(4):
1022 - 1033.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
